The application of exosomes in the treatment of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous and invasive breast cancer (BC) subtype that is estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2 (Her2)-negative. So far, the treatment of TNBC is still ineffective due to the lack of well...
Main Authors: | John W. Weaver, Jinyu Zhang, Juan Rojas, Phillip R. Musich, Zhiqiang Yao, Yong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.1022725/full |
Similar Items
-
DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
by: Stella C. Ogbu, et al.
Published: (2021-12-01) -
Advances in 3D Culture Models to Study Exosomes in Triple-Negative Breast Cancer
by: Neelum Aziz Yousafzai, et al.
Published: (2024-02-01) -
Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
by: Camil Ciprian Mireștean, et al.
Published: (2022-01-01) -
MicroRNAs Associated with Androgen Receptor and Metastasis in Triple-Negative Breast Cancer
by: Mamoun Ahram, et al.
Published: (2024-02-01) -
Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes
by: Kelsee K. Zajac, et al.
Published: (2023-09-01)